Inflammatory signaling pathways were elevated, particularly in high-LPAR6-expressing tumors in all cohorts, and in tumor suppressor pathways apart from DNA repair pathways in high-LPAR1-, LPAR4-, and LPAR6-expressing tumors (Figure 5). This evidence concerns the gene LPAR6 and neoplasm.